Medical Cannabis - Netherlands

Netherlands

Revenue in the Medical Cannabis market is projected to reach US$6.11m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.31%, resulting in a market volume of US$6.52m by 2029.
In global comparison, most revenue will be generated in the United States (US$14,530.00m in 2024).
In relation to total population figures, per person revenues of US$145.90 are generated in 2024.

Key regions: Spain, Europe, Australia, Germany, United States

Market

Region

Region comparison

Currency

Analyst Opinion

The Medical Cannabis market in Netherlands has been experiencing significant growth and development in recent years.

Customer preferences: Customers in the Netherlands are increasingly turning to medical cannabis products due to a growing awareness of the potential health benefits associated with their use. This shift in consumer preferences towards natural and alternative remedies has been a key driver of the market growth.

Trends in the market: One notable trend in the Dutch Medical Cannabis market is the increasing acceptance and legalization of medical cannabis for various health conditions. This has led to a wider range of products being made available to consumers, catering to different needs and preferences. Additionally, there is a growing trend towards research and development in the field of medical cannabis, leading to innovative products and delivery methods.

Local special circumstances: The Netherlands has a long history of tolerance towards cannabis use, which has created a favorable environment for the development of the medical cannabis market. The country's progressive policies and well-established infrastructure for cannabis cultivation have also contributed to the growth of the market. Furthermore, the presence of reputable research institutions and a supportive regulatory framework have encouraged investment and innovation in the sector.

Underlying macroeconomic factors: The Dutch economy's stability and strong healthcare system have provided a solid foundation for the growth of the medical cannabis market. Additionally, the country's strategic location and well-developed trade networks have facilitated the import and export of medical cannabis products, further driving market expansion. Overall, the combination of favorable regulations, consumer preferences, and macroeconomic factors has positioned the Netherlands as a key player in the global medical cannabis market.

Methodology

Data coverage:

Data encompasses B2B and B2C enterprises. Figures are based on companies' revenues, funding values and global consumer survey data. Revenues include retail, sales and taxes.

Modeling approach / Market size:

Market sizes are determined by a Top-Down approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports, third-party data. Next, we use relevant key market indicators and data from country-specific associations such as tobacco spending per capita, medical product spending per capita, consumer spending and consumer spending for recreation purposes, population. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.